vimarsana.com

Latest Breaking News On - March 14 - Page 10 : vimarsana.com

Peru: Metropolitan Lima on red alert starting tonight due to Cyclone Yaku rains | News | ANDINA

Given the latest warm and humid weather conditions caused by Cyclone Yaku, the alert level for Lima Metropolitan Area was increased from orange (strong) to red (extreme), the <a href="https://www.gob.pe/senamhi"target=" blank"

Stoudamire overcome by emotion as he takes over at Ga Tech

Asian markets sink as SVB contagion fears hit banking sector

HONG KONG (AFP): Asian markets sank Tuesday (March 14), with banks bearing the brunt of the selling on fears of contagion in the sector after the collapse of two regional US lenders.

Telix s ZIRCON Phase III Kidney Cancer Imaging Study Presented in Game Changing Session at EAU

MELBOURNE, Australia, March 14, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalTrials.gov Identifier: NCT03849118).1 The results were featured in a "Game Changing" oral session delivered by Professor Dr. Peter Mulders from Radboud University Medical Centre (Netherlands), a ZIRCON Principal Investigator, at the 38th Annual European Association of Urology (EAU) Congress, on Saturday, 11 March 2023. Game Changing sessions are reserved for Phase III trials or other developments that the EAU's Scientific Congress Office believes will have a large impact on daily practice. New data presented: TLX250-CDx demonstrated a high degree of consistency between readers with a very high sensitivity (85.5%) and specificity (87.0%) overall, and 85.5% / 89.5% for small masses

Qritive and Corista Announce Partnership to Advance the Use of Computational Digital Pathology Workflows with Integrated Image Management

SINGAPORE, March 14, 2023 /PRNewswire/ Qritive, a leading developer of artificial intelligence (AI)-powered cancer diagnostics, and, Corista, a leading provider of clinical, research and educational digital pathology image management solutions, are announcing a new partnership in digital pathology. Through the partnership, Qritive's artificial intelligence modules and Corista's DP3 image management platform will be integrated to help pathologist's focus their time towards more complex case work. The combined solution enables computational modules to screen for prostate and colon cancers, quantify IHC markers, and detect lymph node metastasis. With this integrated solution, pathologists will be able to increase their efficiency by prioritizing and grading specific cases, while improving the detection of difficult to diagnose cancers. This enhanced digital pathology workflow will allow for pre-reviewed AI analysis of digital pathology images utilizing any whole slide image s

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.